Package Leaflet: Information for the User
dexketoprofen
Read all of this leaflet carefully before you start taking this medicine, because it contains important information for you.
Follow exactly the administration instructions of the medicine contained in this leaflet or as indicated by your doctor or pharmacist.
Contents of the Package Leaflet:
Contents of the pack and further information
Dexketoprofen is a pain reliever belonging to the group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). It is used to treat short-term pain of mild or moderate intensity, such as muscle or joint pain, menstrual pain (dysmenorrhea), toothache, in adults.
Do not take Dekendol
Warnings and precautions
Consult your doctor or pharmacist before starting to take Dekendol:
Infections
Dexketoprofen may mask the signs of an infection, such as fever and pain. Consequently, it is possible that dexketoprofen may delay the appropriate treatment of the infection, which may increase the risk of complications. This has been observed in bacterial pneumonia and bacterial skin infections related to chickenpox. If you take this medicine while having an infection and the symptoms of the infection persist or worsen, consult a doctor without delay.
Children and adolescents
Dexketoprofen has not been studied in children or adolescents. Therefore, safety and efficacy have not been established, and the product should not be used in children or adolescents.
Other medicines and Dekendol
Tell your doctor or pharmacist if you are using, have recently used, or may need to use any other medicine, even those purchased without a prescription. There are some medicines that should not be taken together, and other medicines that may need a dose change if taken together.
Always inform your doctor, dentist, or pharmacist if, in addition to dexketoprofen, you are taking any of the following medicines:
Not recommended combinations:
Combinations that require caution:
Combinations to be taken into account:
If you have any doubts about taking other medicines with Dekendol, consult your doctor or pharmacist.
Pregnancy, breastfeeding, and fertility
Do not take Dekendol during the last three months of pregnancy or during breastfeeding. Dexketoprofen may cause kidney and heart problems in your fetus. It may affect your and your baby's tendency to bleed and delay or prolong labor more than expected.
If you are pregnant, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine, as dexketoprofen may not be suitable for you.
Women who are planning a pregnancy or are pregnant should avoid using dexketoprofen. Treatment at any time during pregnancy should only be done under the guidance of a doctor. From the 20th week of pregnancy, dexketoprofen may cause kidney problems in your fetus if taken for more than a few days, which may lead to low levels of amniotic fluid surrounding the baby (oligohydramnios) or constriction of a blood vessel (ductus arteriosus) in the baby's heart. If you need treatment for more than a few days, your doctor may recommend additional monitoring.
The use of dexketoprofen is not recommended while trying to conceive or while studying a fertility problem.
Regarding potential effects on female fertility, see also section 2, "Warnings and precautions".
Driving and using machines
Dexketoprofen may slightly affect your ability to drive and use machines, as it may cause drowsiness or dizziness as side effects of treatment. If you notice these effects, do not use machines or drive until these symptoms disappear. Ask your doctor for advice.
Dekendol contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; i.e., it is essentially "sodium-free".
Follow exactly the administration instructions of this medicine contained in this leaflet or as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
In general, the recommended dose is ½ tablet (12.5 mg) every 4-6 hours or 1 tablet (25 mg of dexketoprofen) every 8 hours, not exceeding 3 tablets per day (75 mg).
If you do not feel better or feel worse after 3 or 4 days, you should contact your doctor. Your doctor will indicate how many tablets you should take per day and for how long. The dose of dexketoprofen you need may vary, depending on the type, intensity, and duration of your pain.
The lowest effective dose should be used for the shortest time necessary to relieve symptoms. If you have an infection, consult a doctor without delay if the symptoms (such as fever and pain) persist or worsen (see section 2).
If you are an elderly patient or suffer from kidney or liver disease, it is recommended to start therapy with a maximum of 2 tablets per day (50 mg).
In elderly patients, this initial dose may be increased later according to the general recommended dose (75 mg of dexketoprofen) if dexketoprofen has been well tolerated.
Method of administration
Take the tablets with a sufficient amount of water. Take the tablets with food, as this helps reduce the risk of suffering from side effects in the stomach or intestine. However, if your pain is intense and you need quick relief, take the tablets on an empty stomach (at least 30 minutes before meals) as they will be absorbed more easily.
Use in children and adolescents
This medicine should not be used in children and adolescents (under 18 years of age).
If you take more Dekendol than you should
If you have taken too much medicine, inform your doctor or pharmacist immediately or go to the emergency department of your nearest hospital. Please remember to always carry the medicine packaging or this leaflet with you.
In case of overdose or accidental ingestion, consult your doctor or pharmacist or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Dekendol
Do not take a double dose to make up for forgotten doses. Take the next dose when scheduled (according to section 3 "How to take Dekendol").
If you have doubts about the use of this medicine, consult your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Possible side effects are listed below by frequency.
Common side effects (may affect up to 1 in 10 people)
Nausea and/or vomiting, mainly pain in the upper abdominal quadrant, diarrhea, digestive disorders (dyspepsia).
Uncommon side effects (may affect up to 1 in 100 people)
Dizziness, dizziness, drowsiness, sleep disorders, nervousness, headache, palpitations, hot flashes, inflammation of the stomach wall (gastritis), constipation, dry mouth, flatulence, skin rash, fatigue, pain, feverish sensation, and chills, general malaise.
Rare side effects (may affect up to 1 in 1,000 people)
Peptic ulcer, perforation of peptic ulcer, or bleeding (which may manifest with vomiting blood or black stools), fainting, high blood pressure, slow breathing, fluid retention, and peripheral edema (e.g., swelling of ankles), laryngeal edema, loss of appetite (anorexia), abnormal sensation, pruritic rash, acne, increased sweating, lower back pain, frequent urination, menstrual disorders, prostate disorders, abnormal liver function tests (blood tests), liver cell damage (hepatitis), acute kidney failure.
Very rare side effects (may affect up to 1 in 10,000 people)
Anaphylactic reaction (hypersensitivity reaction that can also lead to collapse), skin ulcers, mouth, eyes, and genital areas (Stevens-Johnson syndrome and Lyell syndrome), facial swelling or swelling of the lips and throat (angioedema), difficulty breathing due to narrowing of the airways (bronchospasm), shortness of breath, tachycardia, low blood pressure, pancreatitis, blurred vision, tinnitus (ringing in the ears), sensitive skin, sensitivity to light, itching, kidney problems. Decreased number of white blood cells (neutropenia), decreased number of platelets (thrombocytopenia).
Tell your doctor immediately if you notice any side effect of a gastrointestinal type at the start of treatment (e.g., stomach pain or burning, or bleeding), if you have previously suffered from any of these side effects due to prolonged treatment with anti-inflammatory drugs, and especially if you are an elderly patient.
Stop taking dexketoprofen immediately if you notice the appearance of a skin rash or any lesion inside the mouth or on the genitals, or any other sign of allergy.
During treatment with non-steroidal anti-inflammatory drugs, cases of fluid retention and swelling (especially in ankles and legs), increased blood pressure, and heart failure have been reported.
Medicines like dexketoprofen may be associated with a small increased risk of suffering from a heart attack ("myocardial infarction") or a stroke ("cerebrovascular accident").
In patients with immune system disorders that affect connective tissue (systemic lupus erythematosus or mixed connective tissue disease), anti-inflammatory medicines can rarely cause fever, headache, and neck stiffness.
The most common side effects observed are of a gastrointestinal type. Peptic ulcers, perforation, or gastrointestinal bleeding may occur, sometimes fatal, especially in elderly patients.
After administration, nausea, vomiting, diarrhea, flatulence, constipation, dyspepsia, abdominal pain, melena, hematemesis, ulcerative stomatitis, worsening of colitis, and Crohn's disease have been reported. Less frequently, gastritis (inflammation of the stomach wall) has been observed.
As with other NSAIDs, hematological reactions (purpura, aplastic anemia, and hemolytic anemia, and more rarely agranulocytosis and bone marrow hypoplasia) may appear.
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after CAD/EXP. The expiry date is the last day of the month indicated.
Store below 30°C.
Medicines should not be disposed of via wastewater or household waste. Dispose of the packaging and any unused medicine in the SIGRE collection point at your pharmacy. If you are unsure, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.
Composition of Dekendol
The active ingredient is dexketoprofen.
Each film-coated tablet contains 25 mg of dexketoprofen (as dexketoprofen trometamol).
The other ingredients (excipients) are microcrystalline cellulose, sodium croscarmellose, corn starch, hypromellose, anhydrous colloidal silica, and magnesium stearate in the tablet core, and hypromellose, macrogol 6000, propylene glycol, and titanium dioxide (E171) in the coating. See section 2 "Dekendol contains sodium".
Appearance and Package Contents of the Product
Film-coated tablet, white to almost white, round, biconvex, and scored on one side.
Dimensions: diameter of approximately 10 mm.
The tablet can be divided into equal doses.
This medicine is available in packs containing 10, 20, 30, and 50 tablets in unit-dose blisters.
Only some pack sizes may be marketed.
Marketing Authorization Holder
TAD Pharma GmbH, Heinz-Lohmann-Straße 5, 27472 Cuxhaven, Germany
Manufacturer
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
or
TAD Pharma GmbH, Heinz-Lohmann-Straße 5, 27472 Cuxhaven, Germany
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
KRKA Farmacéutica, S.L., Calle de Anabel Segura 10, 28108 Alcobendas, Madrid, Spain
This medicine is authorized in the Member States of the European Economic Area under the following names:
Member State | Medicine Name |
Portugal | Dekenor |
Belgium | ??????? 25 mg ????????? ???????? |
Czech Republic | Dekenor |
Slovenia | Dexfenia 25 mg filmsko obložene tablete |
Estonia | Dekenor |
Croatia | Dekenor 25 mg filmom obložene tablete |
Lithuania | Dekenor 25 mg apvalkotas tabletes |
Hungary | Dexfenia 25 mg filmtabletta |
Romania | Dekenor 25 mg comprimate filmate |
Spain | Dekendol 25 mg, film-coated tablets EFG |
Date of the last revision of this prospectus: January 2023
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es//.